North American Cannabis Holdings to Reveal Pending Acquisition into $5 Billion California Cannabis Market This Friday February 16th

North American Cannabis Holdings to Reveal Pending Acquisition into $5 Billion California Cannabis Market This Friday February 16th

DALLAS, TX (Uptick Newswire – February 13, 2018) – North American Cannabis Holdings, Inc. (OTC PINK: USMJ) today announced an online presentation scheduled for February 16th, 2018 to present details surrounding a letter of intent to acquire a business in California intended to position USMJ for entry into California’s cannabis market anticipated to realize $5.1 billion in sales in 2019. The Company recently announced its strategic intentions and developments in California and Canada. Similar progress is anticipated in Canada later this month. Look for the California LOI presentation this Friday on the Company’s website.

North American Cannabis Holdings has published an online presentation on its strategy to be prepared for operations in Canada and California. The presentation is available online at aciconglomerated.com:

McDonald’s of Dispensaries; Sun Maid Raisins of Growers; Splenda of Extracts

For more information on North American Cannabis Holdings and Puration, visit:

www.aciconglomerated.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

For More Information, Contact:

Steven Rash,
info@aciconglomerated.com
1-800-861-1350

Leave a Reply

Close Menu